HealthPhoto: BusinessLineBharat Biotech Cuts Malaria Vaccine Price by 40% via Gavi-UNICEF Deal
Bharat Biotech has reduced the price of its Mosqivac malaria vaccine by approximately 40% through a deal with Gavi and UNICEF. This price cut aims to expand access to the vaccine, potentially benefiting up to 1 million additional children by 2027. The agreement supports wider immunization efforts against malaria in vulnerable populations.
BusinessLine·


